Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.27B
-
Number of holders
-
1803
-
Total 13F shares, excl. options
-
1.09B
-
Shares change
-
-960K
-
Total reported value, excl. options
-
$82.3B
-
Value change
-
+$79.9M
-
Put/Call ratio
-
0.82
-
Number of buys
-
851
-
Number of sells
-
-822
-
Price
-
$75.39
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q3 2025
2,009 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q3 2025.
CVS HEALTH Corp - Common Stock (CVS) has 1,803 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.09B shares
of 1.27B outstanding shares and own 86.08% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (120M shares), VANGUARD GROUP INC (119M shares), Dodge & Cox (73.2M shares), Capital World Investors (68.4M shares), STATE STREET CORP (58.9M shares), FMR LLC (43.3M shares), JPMORGAN CHASE & CO (35.3M shares), GEODE CAPITAL MANAGEMENT, LLC (29M shares), Capital International Investors (26.7M shares), and Invesco Ltd. (24.3M shares).
This table shows the top 1803 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.